News Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing Staff April 23, 2022 Iframe sync Post navigation Previous: The COVID-19 Respiratory Roundtable Issues Joint Letter Urging Canadians to Continue Protecting Each OtherNext: XVIVO Presents Interim Report January-March 2022 More Stories Apps Fitness News Nutrition MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users Staff December 6, 2025 Healthcare News Pharmaceutical AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio Staff December 6, 2025 Cancer Diagnostics DNA Medicare News Patient Care Pharmaceutical Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting Staff December 6, 2025
